MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Neuravi raises $16.7m

Neuravi raises $16.7m

By

NeuraviNeuravi said today it raised $16.7 million (EU €15 million) in a new round of debt financing, with funds slated to support U.S. commercialization and portfolio expansion.

Money in the round came from healthcare alternative financing provider IPF Partners, the Galway, Ireland-based company said.

Funds raised in the round will be invested into the U.S. commercialization of its products and expanding its stroke treatment portfolio, Neuravi said.

“With the recent European launch of the EmboTrap II device and the excellent progress in enrolling our pivotal clinical trial, we are making significant headway in delivering next-generation technology for stroke treatment to physicians. This financing allows us to build our commercial presence in the U.S. and further invest in R&D for our exciting product pipeline. We see significant innovation opportunity due to the under-developed stroke treatment ‘toolbox’ available to stroke clinicians today. Our vision is to design and build devices that truly address the needs of acute stroke patients and put them in the hands of stroke physicians all over the world. This funding is an important step on our roadmap,” CEO Eamon Brady said in a press release.

In September, Neuravi said it won CE Mark approval in the European Union for its EmboTrap II stent retriever and revascularization device.

The device is a next-gen version of the company’s EmboTrap, and is designed to treat a broader range of clots with sizes that are deliverable through a 0.021″ microcatheter.

In case you missed it

RSS From Medical Design & Outsourcing

  • Dymax taps PVA for North American distribution
    Dymax today announced a new North American distribution partnership with PVA. Torrington, Connecticut-based Dymax — which develops rapid and light-curable materials, dispensing equipment and UV/LED curing systems for the medical device industry and others — said the agreement with PVA covers adhesives, maskants and conformal coatings. Founded in 1992 as Precision Valve & Automation, Cohoes,… […]
  • Proto Labs stock dives on Q3 earnings miss
    Proto Labs (NYSE:PRLB) stock dropped more than 18% after the digital manufacturing service provider reported third-quarter earnings that missed Wall Street’s expectations. Maple Plain, Minnesota–based Proto Labs this morning reported earnings of $4.8 million (or 17¢ per share) off sales of $125.3 million. That’s a 67% decrease from Q3 2020’s earnings of $14.7 million (55¢… […]
  • Philips says more than 1,000 medical devices types can connect to its information platform
    Royal Philips (NYSE: PHG, AEX: PHIA) today announced the release of new device drivers that enable its Philips Capsule Medical Device Information Platform (MDIP) to integrate with more than 1,000 unique types of medical devices. Philips Capsule MDIP can also integrate into the Philips HealthSuite Platform, installed in more than 3,000 healthcare facilities worldwide. Philips… […]
  • Integer beats The Street in Q3, plans to acquire Oscor
    Integer Holdings (NYSE:ITGR) posted third-quarter results today that beat the consensus forecast on Wall Street — and announced plans to spend $220 million to acquire Oscor. The Plano, Texas–based medtech contract manufacturing giant plans to finance the acquisition with debt. Integer officials expect the deal to close in December under customary closing conditions. They see… […]
  • West Pharmaceutical Services beats Street in Q3, raises guidance
    West Pharmaceutical Services (NYSE:WST) shares rose slightly today on third-quarter results that topped the consensus forecast. The Exton, Pennsylvania-based maker of injectable drug packaging and delivery systems posted profits of $175.6 million, or $2.31 per share, on sales of $706.5 million for the three months ended Sept. 30, 2021, more than doubling its bottom-line on sales… […]
  • Edwards Lifesciences stock slides on Q3 financial results
    Edwards Lifesciences (NYSE: EW) reported third-quarter financial results today that exceeded Wall Street’s expectations on profits but narrowly missed on sales. The Irvine, California–based cardio device company reported earnings of $340.1 million (or 54¢ per share) off sales of $1.31 billion. That’s a 4.6% increase from Q3 2020’s earnings of $325.2 million (52¢ per share) off sales… […]
  • BICO’s Scienion and Cellenion launch SpheroOne large-particle sorter and dispenser
    BICO Group subsidiaries Scienion and Cellenion today announced the launch of their SpheroOne single large-particle sorter and dispenser for drug testing using complex in-vitro 3D models. The SpheroOne platform can dispense individual spheroids, organoids and tumoroids, handling cellular aggregates ranging from 80 µm to 600 µm and complementing Cellenion’s CellenOne platform for sorting and dispensing… […]
  • Thermo Fisher Scientific ticks up on Street-beating Q3 results
    Thermo Fisher Scientific (NYSE:TMO) today posted third-quarter results that beat the overall consensus on Wall Street. The Waltham, Massachusetts–based laboratory supply company reported profits of $1.9 billion, or $4.79 per share, on sales of $9.3 billion for the three months ended Oct. 2, for a bottom-line loss of 1.6% on sales growth of 9.49% compared with… […]
  • Emerson introduces new miniature rocker isolation valve for clinical lab instruments
    Emerson (NYSE:EMR) has launched the ASCO Series 062 rocker isolation valve, designed for hematology and immunoassay analyzers, sample preparation and pre-analytical, as well as DNA sequencing instruments. The St. Louis, Missouri-based company said the two-way and three-way valves are compact at 16mm, allowing for easy integration into complex fluid-handling manifolds while reducing their footprint, weight… […]
  • Medtronic faces longer road to renal denervation
    Medtronic (NYSE:MDT) will continue the clinical study of its Symplicity Spyral renal denervation (RDN) system for hypertension into next year after lacking the positive results needed to end enrollment early. Fridley, Minnesota-based Medtronic said last month that it hoped to present results of the Spyral HTN-ON MED trial at the Cardiovascular Research Foundation’s TCT Conference… […]
  • Cadence is expanding in Pennsylvania
    Cadence (Staunton, Virginia) announced today that it is expanding its Product Realization Center in Cranberry Township, Pennsylvania. The company expects to finish the 21,000-square-foot expansion by March 2022. The expanded manufacturing footprint will include an additional Class 7 (10,000) cleanroom by the end of 2022. “Everything lined up so well for this expansion to take… […]